Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial (Q34622281)
Jump to navigation
Jump to search
scientific article published on August 4, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial |
scientific article published on August 4, 2010 |
Statements
1 reference
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial (English)
1 reference
Gen Sobue
1 reference
Masahisa Katsuno
1 reference
Haruhiko Banno
1 reference
Keisuke Suzuki
1 reference
Yu Takeuchi
1 reference
Motoshi Kawashima
1 reference
Ichiro Yabe
1 reference
Hidenao Sasaki
1 reference
Mitsuya Morita
1 reference
Imaharu Nakano
1 reference
Kazuaki Kanai
1 reference
Shoichi Ito
1 reference
Kinya Ishikawa
1 reference
Hidehiro Mizusawa
1 reference
Tomotaka Yamamoto
1 reference
Shoji Tsuji
1 reference
Kazuko Hasegawa
1 reference
Takayoshi Shimohata
1 reference
Masatoyo Nishizawa
1 reference
Hiroaki Miyajima
1 reference
Fumio Kanda
1 reference
Yasuhiro Watanabe
1 reference
Kenji Nakashima
1 reference
Akira Tsujino
1 reference
Taro Yamashita
1 reference
Makoto Uchino
1 reference
Yasushi Fujimoto
1 reference
Fumiaki Tanaka
1 reference
Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group
1 reference
4 August 2010
1 reference
1 reference
9
1 reference
9
1 reference
875-884
1 reference
Identifiers
1 reference
1 reference